160 related articles for article (PubMed ID: 27647924)
1. ACOX2 deficiency: A disorder of bile acid synthesis with transaminase elevation, liver fibrosis, ataxia, and cognitive impairment.
Vilarinho S; Sari S; Mazzacuva F; Bilgüvar K; Esendagli-Yilmaz G; Jain D; Akyol G; Dalgiç B; Günel M; Clayton PT; Lifton RP
Proc Natl Acad Sci U S A; 2016 Oct; 113(40):11289-11293. PubMed ID: 27647924
[TBL] [Abstract][Full Text] [Related]
2. ACOX2 deficiency: An inborn error of bile acid synthesis identified in an adolescent with persistent hypertransaminasemia.
Monte MJ; Alonso-Peña M; Briz O; Herraez E; Berasain C; Argemi J; Prieto J; Marin JJG
J Hepatol; 2017 Mar; 66(3):581-588. PubMed ID: 27884763
[TBL] [Abstract][Full Text] [Related]
3. A novel case of ACOX2 deficiency leads to recognition of a third human peroxisomal acyl-CoA oxidase.
Ferdinandusse S; Denis S; van Roermund CWT; Preece MA; Koster J; Ebberink MS; Waterham HR; Wanders RJA
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):952-958. PubMed ID: 29287774
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia.
Alonso-Peña M; Espinosa-Escudero R; Herraez E; Briz O; Cagigal ML; Gonzalez-Santiago JM; Ortega-Alonso A; Fernandez-Rodriguez C; Bujanda L; Calvo Sanchez M; D Avola D; Londoño MC; Diago M; Fernandez-Checa JC; Garcia-Ruiz C; Andrade RJ; Lammert F; Prieto J; Crespo J; Juamperez J; Diaz-Gonzalez A; Monte MJ; Marin JJG
Hepatology; 2022 Nov; 76(5):1259-1274. PubMed ID: 35395098
[TBL] [Abstract][Full Text] [Related]
5. Association of the liver peroxisomal fatty acyl-CoA beta-oxidation system with the synthesis of bile acids.
Hayashi H; Fukui K; Yamasaki F
J Biochem; 1984 Dec; 96(6):1713-9. PubMed ID: 6530393
[TBL] [Abstract][Full Text] [Related]
6. [Peroxisomal beta-oxidation].
Mannaerts GP; Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
[TBL] [Abstract][Full Text] [Related]
7. A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids.
Savolainen K; Kotti TJ; Schmitz W; Savolainen TI; Sormunen RT; Ilves M; Vainio SJ; Conzelmann E; Hiltunen JK
Hum Mol Genet; 2004 May; 13(9):955-65. PubMed ID: 15016763
[TBL] [Abstract][Full Text] [Related]
8. Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta 4-3-oxosteroid 5 beta-reductase deficiency).
Daugherty CC; Setchell KD; Heubi JE; Balistreri WF
Hepatology; 1993 Nov; 18(5):1096-101. PubMed ID: 8225213
[TBL] [Abstract][Full Text] [Related]
9. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
Van Veldhoven PP
Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
[TBL] [Abstract][Full Text] [Related]
10. Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis.
Setchell KD; Suchy FJ; Welsh MB; Zimmer-Nechemias L; Heubi J; Balistreri WF
J Clin Invest; 1988 Dec; 82(6):2148-57. PubMed ID: 3198770
[TBL] [Abstract][Full Text] [Related]
11. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system.
Reddy JK; Hashimoto T
Annu Rev Nutr; 2001; 21():193-230. PubMed ID: 11375435
[TBL] [Abstract][Full Text] [Related]
12. A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3.
Ferdinandusse S; Jimenez-Sanchez G; Koster J; Denis S; Van Roermund CW; Silva-Zolezzi I; Moser AB; Visser WF; Gulluoglu M; Durmaz O; Demirkol M; Waterham HR; Gökcay G; Wanders RJ; Valle D
Hum Mol Genet; 2015 Jan; 24(2):361-70. PubMed ID: 25168382
[TBL] [Abstract][Full Text] [Related]
13. Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy.
Setchell KD; Heubi JE; Bove KE; O'Connell NC; Brewsaugh T; Steinberg SJ; Moser A; Squires RH
Gastroenterology; 2003 Jan; 124(1):217-32. PubMed ID: 12512044
[TBL] [Abstract][Full Text] [Related]
14. Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency.
Ferdinandusse S; Denis S; Hogenhout EM; Koster J; van Roermund CW; IJlst L; Moser AB; Wanders RJ; Waterham HR
Hum Mutat; 2007 Sep; 28(9):904-12. PubMed ID: 17458872
[TBL] [Abstract][Full Text] [Related]
15. Peroxisomal bifunctional enzyme deficiency.
Watkins PA; Chen WW; Harris CJ; Hoefler G; Hoefler S; Blake DC; Balfe A; Kelley RI; Moser AB; Beard ME
J Clin Invest; 1989 Mar; 83(3):771-7. PubMed ID: 2921319
[TBL] [Abstract][Full Text] [Related]
16. Acox2 is a regulator of lysine crotonylation that mediates hepatic metabolic homeostasis in mice.
Zhang Y; Chen Y; Zhang Z; Tao X; Xu S; Zhang X; Zurashvili T; Lu Z; Bayascas JR; Jin L; Zhao J; Zhou X
Cell Death Dis; 2022 Mar; 13(3):279. PubMed ID: 35351852
[TBL] [Abstract][Full Text] [Related]
17. [Inborn errors of bile acid metabolism].
Stellaard F; Wolthers BG
Tijdschr Kindergeneeskd; 1993 Aug; 61(4):125-34. PubMed ID: 8122223
[TBL] [Abstract][Full Text] [Related]
18. [Effects of activation of liver X receptor and peroxisome proliferator-activated receptor alpha on bile acid synthesis in rats].
Ma Y; Jiang LL; Shi RL; Liu J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):384-7. PubMed ID: 17633467
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of ACOX2 in non-small cell lung cancer.
Sui JSY; Martin P; Keogh A; Murchan P; Ryan L; Nicholson S; Cuffe S; Broin PÓ; Finn SP; Fitzmaurice GJ; Ryan R; Young V; Gray SG
BMC Pulm Med; 2022 Aug; 22(1):321. PubMed ID: 35999530
[TBL] [Abstract][Full Text] [Related]
20. [Clinical feature and genetic analysis of a family affected by congenital bile acid synthesis defect type 2: identification of 2 novel mutations in AKR1D1 gene].
Cheng Y; Guo L; Deng M; Song YZ
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jul; 19(7):734-740. PubMed ID: 28697823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
